Hero background
Sponsored by CAS

Webinar: Use Sequence Data to Strengthen Biologics Patent Claims and Applications

Nearly 30% of biologics patent rejections result from a lack of adequate description. Rejections of this sort may rise in light of the Supreme Court’s decision in Amgen v. Sanofi. Increasingly, building strong patent applications in this complex and litigious biologics space will require more robust specifications, with solid and well-supported claims, which means applications backed by strong IP searches are essential.

Join us for a webinar on Tuesday, August 29, 2023, at 12 PM ET, to discuss where we are currently and where we are heading after Amgen v. Sanofi. Our panel of industry experts will discuss challenges and ways to use quality sequence data more effectively to build stronger biologics patent claims and applications.

Joining moderator Gene Quinn, Founder, President & CEO of IPWatchdog, Inc., will be Lisa L. Mueller, J.D., B.S., Shareholder, Casimir Jones, S.C., Raymond N. Russell, J.D., Ph.D., Partner, Tarolli, Sundheim, Covell & Tummino LLP, and Anne Marie Clark, Ph.D., Senior Scientist, CAS IP Services.

What you will learn:

  • Avoiding claims pitfalls with competent sequence search strategies
  • Insights to ensure biologics claims meet novelty and obviousness
  • How recent court rulings are affecting written claims
  • When and why to make go/no-go application decisions
  • Amending claims as new research data arises to capture IP value

Our Webinar Sponsor